Caplight Directory>Companies>Ability Biotherapeutics-preview>Ability


Ability Biotherapeutics

Ability Biotherapeutics

Private
MontrealHealthcare & Life Scienceshttps://ability.bio

Last Round

Seed

Jun 18, 2024

Total Funding Raised

$18M

Company Overview

Ability Biotherapeutics is a biotherapeutics company that develops logic-gated antibody therapeutics for cancer and autoimmune diseases using its proprietary AI-powered discovery platform, AbiLeap™.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, Precision Medicine

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Application

Keywords

logic-gated antibodiesgenerative AI for drug discoveryantibody therapeuticsAI drug discoveryantibody discoveryimmuno-oncologysmart antibodiesT-cell engagersbispecific antibodiesautoimmune diseasesdrug discovery platformmicroenvironment targetingconditionally activated antibodiespH-activated antibodiespreclinical biotechbiopharma partnershipsfully human antibodiesbiologics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ability Biotherapeutics Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ability Biotherapeutics Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedJun 18, 2024
SeedDec 6, 2023
View all Funding Rounds

Key People

Founding team and executive leadership

Bharat Srinivasa

Founding CEO And Board Observer

Founding Team

Giles Day

Chief Executive Officer

Executive Team

Patrick Tremblay

Chief Operating Officer

Executive Team

Ability Biotherapeutics Investors

Notable investors and investment history

InvestorRounds
Amplitude VenturesSeed
Investissement QuébecSeed
Fonds de solidarité FTQSeed
Alexandria Venture InvestmentsSeed
TheodorusSeed
Page One VenturesSeed
View all Investors

Ability Biotherapeutics Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ability Biotherapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ability Biotherapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMontreal
Employee Range25
Year Founded2023
Last FundingJun 18, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.